Fairmont Banff Springs Floorplan
Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
This meeting took place in 2018
Here are the related meetings in 2019:
Microbiome: Chemical Mechanisms and Biological Consequences (C3)
For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.
Manipulation of the Gut Microbiota for Metabolic Health (X3)
Organizer(s) Nathalie Delzenne and Liping Zhao
March 4—8, 2018
Fairmont Banff Springs • Banff, Alberta Canada
Discounted Abstract Deadline: Nov 1, 2017
Abstract Deadline: Dec 1, 2017
Scholarship Deadline: Nov 1, 2017
Discounted Registration Deadline: Jan 9, 2018
Sponsored by Merck & Co., Inc. and Takeda Pharmaceutical Company Limited
Joint Meeting:
Microbiome, Host Resistance and Disease (X4)
Summary of Meeting:
The main objective of this Keystone Symposia conference is to evaluate the contribution of the gut microbiota to diseases characterized by alterations of host energy metabolism, and to highlight development of new therapeutic and nutritional approaches. Innovative models allow us to better elaborate the link between gut microbiota, the environment (including nutrition and xenobiotics – drugs, contaminants, additives) and host physiology, namely by focusing on specific metabolites produced by the gut microbes. As compared to previous meetings organized in the same field, additional metabolic disorders will be covered, including undernutrition and cachexia, disturbances of gut-muscle axis and cardiovascular dysfunction. Special attention will be brought to innovative tools to manipulate the gut microbiota, implicating both academic and industry research. The symposium will bring together a multidisciplinary audience to explore the vast amount of existing data (metagenomics and metabolomics dataset) that can be leveraged to elaborate novel tools to modulate the gut microbiota for host health.
View Scholarships/Awards
The main objective of this Keystone Symposia conference is to evaluate the contribution of the gut microbiota to diseases characterized by alterations of host energy metabolism, and to highlight development of new therapeutic and nutritional approaches. Innovative models allow us to better elaborate the link between gut microbiota, the environment (including nutrition and xenobiotics – drugs, contaminants, additives) and host physiology, namely by focusing on specific metabolites produced by the gut microbes. As compared to previous meetings organized in the same field, additional metabolic disorders will be covered, including undernutrition and cachexia, disturbances of gut-muscle axis and cardiovascular dysfunction. Special attention will be brought to innovative tools to manipulate the gut microbiota, implicating both academic and industry research. The symposium will bring together a multidisciplinary audience to explore the vast amount of existing data (metagenomics and metabolomics dataset) that can be leveraged to elaborate novel tools to modulate the gut microbiota for host health.
View Scholarships/Awards
No registration fees are used to fund entertainment or alcohol at this conference
The meeting will begin on Sunday, March 4 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 8 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 9 in order to fully experience the meeting.
SUNDAY, MARCH 4
MONDAY, MARCH 5
TUESDAY, MARCH 6
WEDNESDAY, MARCH 7
THURSDAY, MARCH 8
FRIDAY, MARCH 9
Conference Program Print | View meeting in 24 hr (international) time
The meeting will begin on Sunday, March 4 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 8 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 9 in order to fully experience the meeting.
SUNDAY, MARCH 4
6:00—8:00 PM
Welcome Mixer
No registration fees are used to fund alcohol served at this function.
8:00—9:00 AM
Welcome and Keynote Address (Joint)
Meeting has ended...abstracts no longer viewable online.
*
Yasmine Belkaid,
NIAID, National Institutes of Health, USA
*
Janelle S. Ayres,
The Salk Institute for Biological Studies, USA
*
Nathalie Delzenne,
Université Catholique de Louvain, Belgium
*
Liping Zhao,
Shanghai Jiao Tong University, China and Rutgers University, USA
Andreas J. Bäumler,
University of California, Davis, USA
Healthy Guts Exclude Oxygen
Healthy Guts Exclude Oxygen
9:00—11:30 AM
Microbiota and Cardiovascular-Metabolic Health (Joint)
Meeting has ended...abstracts no longer viewable online.
*
Lora V. Hooper,
University of Texas Southwestern Medical Center, USA
*
Fredrik Bäckhed,
University of Gothenburg, Sweden
Mechanistic Studies of the Impact of the Gut Microbiome on Obesity and Type 2 Diabetes
Mechanistic Studies of the Impact of the Gut Microbiome on Obesity and Type 2 Diabetes
Coffee Break
Liping Zhao,
Shanghai Jiao Tong University, China and Rutgers University, USA
Ecological Understanding of the Causative Role of Gut Microbiota in Human Metabolic Health
Ecological Understanding of the Causative Role of Gut Microbiota in Human Metabolic Health
Julia H. Kreznar,
University of Wisconsin-Madison, USA
Short Talk: Identifying the Genetic Determinants of Gut Microbiome Composition on a Western Diet
Short Talk: Identifying the Genetic Determinants of Gut Microbiome Composition on a Western Diet
Amy McMillan,
Cleveland Clinic, USA
Short Talk: The Gut Microbe-Dependent Metabolite Trimethylamine N-oxide (TMAO) Is Associated with Multiple Measures of Periodontal Disease and Cardiovascular Disease Risk
Short Talk: The Gut Microbe-Dependent Metabolite Trimethylamine N-oxide (TMAO) Is Associated with Multiple Measures of Periodontal Disease and Cardiovascular Disease Risk
2:30—4:30 PM
Workshop: Metagenomic, Metatranscriptomic and Multi’Omic Microbiome Analyses (Joint)
This workshop will provide an introduction to study design tools and analysis methods for emerging molecular tools in human microbiome population studies, integrating detailed metagenomic, metatranscriptomic, and other culture-independent molecular methods. Alternating between lecture content and hands-on activities, tutorial presentations will walk attendees through the typical steps in a meta’omic study design and analysis workflow: 1) integration of multiple molecular techniques within a study, 2) bioinformatics for metagenomes and metatranscriptomes, 3) and profiling of microbial community features (taxa, strains, pathways, genes, small molecules, and others). The hands-on components of the tutorial will introduce the bioBakery suite of meta’omic analysis methods, which are publicly available and will be used online through a cloud interface during the workshop. Attendees will work on their personal laptops and interact with their instances through a web browser-based graphical interface (https://bitbucket.org/biobakery/biobakery/wiki/biobakery_workshop).
Tutorial Schedule:
Multi’omics for human microbiome studies (20 minutes, Curtis Huttenhower)
Tutorial setup (15 minutes, Melanie Schirmer)
Metagenome taxonomic and strain profiling (20 minutes, Kevin Bonham)
Lab: StrainPhlAn (25 minutes, Kevin Bonham)
Meta’omic functional profiling (15 minutes, Eric Franzosa)
Lab: HUMAnN2 (25 minutes, Eric Franzosa)
Tutorial Schedule:
Multi’omics for human microbiome studies (20 minutes, Curtis Huttenhower)
Tutorial setup (15 minutes, Melanie Schirmer)
Metagenome taxonomic and strain profiling (20 minutes, Kevin Bonham)
Lab: StrainPhlAn (25 minutes, Kevin Bonham)
Meta’omic functional profiling (15 minutes, Eric Franzosa)
Lab: HUMAnN2 (25 minutes, Eric Franzosa)
*
Curtis Huttenhower,
Harvard School of Public Health, USA
5:00—7:15 PM
The Gut Microbiome in the Control of Fat Metabolism (Joint)
Meeting has ended...abstracts no longer viewable online.
*
Fredrik Bäckhed,
University of Gothenburg, Sweden
*
Anna Mae Diehl,
Duke University, USA
The Gut Microbiome and NAFLD Pathogenesis
The Gut Microbiome and NAFLD Pathogenesis
Mirko Trajkovski,
University of Geneva - CMU, Switzerland
The Microbiota and the Browning of Adipose Tissue
The Microbiota and the Browning of Adipose Tissue
Patrice D. Cani,
UCLouvain, Belgium
Intestinal Endocannabinoids, Gut Microbes and Adiposity: Novel Mechanisms
Intestinal Endocannabinoids, Gut Microbes and Adiposity: Novel Mechanisms
Kelsey E. Huus,
University of British Columbia, Canada
Short Talk: The Development of IgA-Lactobacillus Interactions Is Disrupted during Malnutrition and Environmental Enteropathy
Short Talk: The Development of IgA-Lactobacillus Interactions Is Disrupted during Malnutrition and Environmental Enteropathy
Philippe Gerard,
INRA, France
Short Talk: A Bacterial Species Isolated from an Obese Human Gut Triggers Non-Alcoholic Fatty Liver Disease in Germ-Free Mice through Lps-Dependent Mechanism
Short Talk: A Bacterial Species Isolated from an Obese Human Gut Triggers Non-Alcoholic Fatty Liver Disease in Germ-Free Mice through Lps-Dependent Mechanism
7:15—8:15 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
8:00—11:15 AM
Microbiota and Metabolic Disorders
Meeting has ended...abstracts no longer viewable online.
*
Ruth E. Ley,
Max Planck Institute for Developmental Biology, Germany
Emily P. Balskus,
Harvard University, USA
Deciphering Gut Microbiota-Drug Interactions with Chemistry
Deciphering Gut Microbiota-Drug Interactions with Chemistry
François Leulier,
Institut de Génomique Fonctionnelle de Lyon, France
Host-Microbiota Mutualism upon Chronic Undernutrition: Lessons from Gnotobiotic Animal Models
Host-Microbiota Mutualism upon Chronic Undernutrition: Lessons from Gnotobiotic Animal Models
Coffee Break
Herbert Tilg,
Medical University Innsbruck, Austria
Microbiome and Liver Diseases
Microbiome and Liver Diseases
Eran Elinav,
Weizmann Institute of Science, Israel
Host Microbiome Interactions in Health and Disease
Host Microbiome Interactions in Health and Disease
Chenhong Zhang,
Shanghai Jiao Tong University, China
Short Talk: Predominant Gut Lactobacillus murinus Strain Mediates the Anti-Inflammaging Effects in Calorie-Restricted Mice
Short Talk: Predominant Gut Lactobacillus murinus Strain Mediates the Anti-Inflammaging Effects in Calorie-Restricted Mice
Tim Hendrikx,
University of California, San Diego, USA
Short Talk: Engineered Lactobacillus reuteri that Secretes IL-22 in the Gut Ameliorates Alcohol-Induced Liver Damage in Mice by Inducing Antimicrobial Molecules Reg3β and Reg3γ
Short Talk: Engineered Lactobacillus reuteri that Secretes IL-22 in the Gut Ameliorates Alcohol-Induced Liver Damage in Mice by Inducing Antimicrobial Molecules Reg3β and Reg3γ
8:00—11:15 AM
The Microbiota of Early Life and Developmental Immunology
Meeting has ended...abstracts no longer viewable online.
Maria G. Dominguez-Bello,
Rutgers University, USA
Effect of C-Section on the Microbiota and Host Phenotype
Effect of C-Section on the Microbiota and Host Phenotype
*
Andrew J.S. Macpherson,
University of Bern, Switzerland
The Maternal Microbiota and Early Postnatal Innate Immune Development
The Maternal Microbiota and Early Postnatal Innate Immune Development
Coffee Break
Gregory M. Barton,
University of California, Berkeley, USA
Determinants of CD4 T Cell Responses to the Microbiota
Determinants of CD4 T Cell Responses to the Microbiota
Michael D. Rosenblum,
University of California, San Francisco, USA
Neonatal Regulatory T Cells and Immune Tolerance to Skin Commensals
Neonatal Regulatory T Cells and Immune Tolerance to Skin Commensals
Brittany Needham,
California Institute of Technology, USA
Short Talk: Gut Bacterial Production of a Single Metabolite Causes Behavioral Abnormalities Related to Anxiety and Autism Spectrum Disorder
Short Talk: Gut Bacterial Production of a Single Metabolite Causes Behavioral Abnormalities Related to Anxiety and Autism Spectrum Disorder
Michael G. Constantinides,
NIAID, National Institutes of Health, USA
Short Talk: Mucosal-Associated Invariant T Cells Respond to Cutaneous Microbiota
Short Talk: Mucosal-Associated Invariant T Cells Respond to Cutaneous Microbiota
2:30—4:30 PM
Workshop and Panel: Discovery, Translation and Commercialization in Microbiome Research and Development: Opportunities and Challenges
David N. Cook,
Seres Therapeutics, Inc., USA
Treating IBD with Multi-Species Bacterial Consortia
Treating IBD with Multi-Species Bacterial Consortia
Henry J. Haiser,
Novartis Institutes for BioMedical Research, USA
Facing the Challenges and Opportunities of Microbiome Research—a Big Pharma Perspective
Facing the Challenges and Opportunities of Microbiome Research—a Big Pharma Perspective
*
Thomas Gajewski,
University of Chicago, USA
Prospect of Manipulating the Microbiota as a Cancer Immunotherapeutic
Prospect of Manipulating the Microbiota as a Cancer Immunotherapeutic
Maria G. Dominguez-Bello,
Rutgers University, USA
Challenges in Translation of Microbiome Research
Challenges in Translation of Microbiome Research
5:00—7:00 PM
Gut Barrier Alterations and Host Metabolic Disorders
Meeting has ended...abstracts no longer viewable online.
*
Robert W. Karp,
National Institutes of Health, USA
Lora V. Hooper,
University of Texas Southwestern Medical Center, USA
How the Microbiota, the Immune System and the Circadian Clock Interact to Regulate Metabolism
How the Microbiota, the Immune System and the Circadian Clock Interact to Regulate Metabolism
Philippe Langella,
Institut National de la Recherche Agronomique, France
Microbial Bioactive Metabolites and Gut Function
Microbial Bioactive Metabolites and Gut Function
Michiel Kleerebezem,
Wageningen University, Netherlands
Small Intestine Microbiota and Host Metabolism
Small Intestine Microbiota and Host Metabolism
Jun Sun,
University of Illinois at Chicago, USA
Short Talk: Vitamin D Receptor Regulation of Microbiome in Inflammation and Obesity
Short Talk: Vitamin D Receptor Regulation of Microbiome in Inflammation and Obesity
5:00—7:00 PM
Mechanistics Microbiome Function in Physiology and Aging
Meeting has ended...abstracts no longer viewable online.
*
Janelle S. Ayres,
The Salk Institute for Biological Studies, USA
Meghan A. Koch,
University of California, Berkeley, USA
Maternal Antibodies Regulate Neonatal Health
Maternal Antibodies Regulate Neonatal Health
Sarkis K. Mazmanian,
California Institute of Technology, USA
Gut Microbiomes from Human Autism Spectrum Disorder Alter Behaviors in Mice
Gut Microbiomes from Human Autism Spectrum Disorder Alter Behaviors in Mice
Nicholas Bessman,
Weill Cornell Medicine, USA
Short Talk: A Dendritic Cell-Derived Hormone Regulates Microbiome Colonization and Repair in the Intestine
Short Talk: A Dendritic Cell-Derived Hormone Regulates Microbiome Colonization and Repair in the Intestine
Rachel R. Caspi,
NEI, National Institutes of Health, USA
Short Talk: The Good and The Bad: Two Faces of an Ocular Surface Commensal
Short Talk: The Good and The Bad: Two Faces of an Ocular Surface Commensal
7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
8:00—11:15 AM
Feeding the Gut Microbiota for Health
Meeting has ended...abstracts no longer viewable online.
*
Liping Zhao,
Shanghai Jiao Tong University, China and Rutgers University, USA
Jens Walter,
University of Alberta, Canada
Modulation of the Human Gut Microbiota with Non-Digestible Carbohydrates – An Ecological Perspective
Modulation of the Human Gut Microbiota with Non-Digestible Carbohydrates – An Ecological Perspective
Nathalie Delzenne,
Université Catholique de Louvain, Belgium
Feeding the Gut Microbiota with Prebiotics: Which Consequence for Host Health?
Feeding the Gut Microbiota with Prebiotics: Which Consequence for Host Health?
Coffee Break
André Marette,
Laval University Hospital Research Center, Canada
Exploring the Interaction between Dietary Polyphenols and the Gut Microbiota to Alleviate Obesity-Linked Diseases
Exploring the Interaction between Dietary Polyphenols and the Gut Microbiota to Alleviate Obesity-Linked Diseases
Maria Carmen Collado,
Institute of Agrochemistry and Food Technology-Spanish National Research Council, Spain
Maternal Microbiome and its Role in Infant Health
Maternal Microbiome and its Role in Infant Health
Long H. Nguyen,
Massachusetts General Hospital, USA
Short Talk: The Influence of Dietary Patterns and Intake of Sulfur on Sulfate-Reducing Bacteria Abundance and Function
Short Talk: The Influence of Dietary Patterns and Intake of Sulfur on Sulfate-Reducing Bacteria Abundance and Function
Jared D. Hoffman,
University of Kentucky, USA
Short Talk: Prebiotics for the Gut Microbiota as an Intervention for Alzheimer's Disease Prevention in APOE4 Carriers
Short Talk: Prebiotics for the Gut Microbiota as an Intervention for Alzheimer's Disease Prevention in APOE4 Carriers
8:00—11:15 AM
The Microbiota and Resistance to Infectious Diseases
Meeting has ended...abstracts no longer viewable online.
*
Sara R. Cherry,
University of Pennsylvania School of Medicine, USA
Defining the Inter-Kingdom Interactions that Impact Enteric Viral Infections
Defining the Inter-Kingdom Interactions that Impact Enteric Viral Infections
Howard C. Hang,
Rockefeller University, USA
Chemical Dissection of Gut Bacteria Protection Mechanisms
Chemical Dissection of Gut Bacteria Protection Mechanisms
Coffee Break
Kerwyn Casey Huang,
Stanford University, USA
Resilience of the Gut Microbiota to Perturbations
Resilience of the Gut Microbiota to Perturbations
Ken H. Cadwell,
New York University School of Medicine, USA
Transkingdom Interactions and Colonization Resistance
Transkingdom Interactions and Colonization Resistance
Jeffrey R. Singer,
University of Alabama at Birmingham, USA
Short Talk: Intestinal Oxygen Regulates Primary Succession and Opportunistic Overgrowth in a Murine Model of Late-Onset Sepsis
Short Talk: Intestinal Oxygen Regulates Primary Succession and Opportunistic Overgrowth in a Murine Model of Late-Onset Sepsis
Shai Bel,
Bar-Ilan University, Israel
Short Talk: Paneth Cells Secrete Lysozyme via Secretory Autophagy during Bacterial Infection of the Intestine
Short Talk: Paneth Cells Secrete Lysozyme via Secretory Autophagy during Bacterial Infection of the Intestine
5:00—7:00 PM
Xenobiotics-Microbiota Interactions in Metabolic Diseases
Meeting has ended...abstracts no longer viewable online.
*
Nathalie Delzenne,
Université Catholique de Louvain, Belgium
Mark R. Charbonneau,
Synlogic, USA
A Genetically Engineered E. coli Nissle to Prevent Hyperammonemia in Urea Cycle Disorders (UCDs)
A Genetically Engineered E. coli Nissle to Prevent Hyperammonemia in Urea Cycle Disorders (UCDs)
Leah Guthrie,
Albert Einstein College of Medicine, USA
Short Talk: Human Microbiome Signatures of Differential Colorectal Cancer Drug Metabolism
Short Talk: Human Microbiome Signatures of Differential Colorectal Cancer Drug Metabolism
Silke S. Heinzmann,
Helmholtz Centre Munich, Germany
Short Talk: Endogenous and Host-Microbial Co-Metabolites in Human Biofluids to Investigate Gut Microbiome Functionality
Short Talk: Endogenous and Host-Microbial Co-Metabolites in Human Biofluids to Investigate Gut Microbiome Functionality
James R. Brown,
GlaxoSmithKline, USA
Short Talk: A Chemogenomics Approach for the Discovery of Human Host Receptor Interactions with Endogenous Microbial Metabolites
Short Talk: A Chemogenomics Approach for the Discovery of Human Host Receptor Interactions with Endogenous Microbial Metabolites
Leyuan Li,
University of Ottawa, Canada
Short Talk: Rapid Assay of Individuals' Microbiome (RapidAIM) for Understanding Drug-Microbiome Interaction and High-Throughput Drug Screening
Short Talk: Rapid Assay of Individuals' Microbiome (RapidAIM) for Understanding Drug-Microbiome Interaction and High-Throughput Drug Screening
5:00—7:00 PM
Disease Tolerance, Pathology and the Microbiome
Meeting has ended...abstracts no longer viewable online.
Yasmine Belkaid,
NIAID, National Institutes of Health, USA
Control of Tissue Immunity and Repair by the Microbiota
Control of Tissue Immunity and Repair by the Microbiota
Janelle S. Ayres,
The Salk Institute for Biological Studies, USA
Micronutrient Metabolism Mediates Healthy Host-Pathogen Interactions
Micronutrient Metabolism Mediates Healthy Host-Pathogen Interactions
*
Denise M. Monack,
Stanford University, USA
Microbiota Regulation of Salmonella Persistence and Disease Transmission
Microbiota Regulation of Salmonella Persistence and Disease Transmission
Zhenrun Jerry Zhang,
Rockefeller University, USA
Short Talk: Control of Salmonella Virulence by Microbiota-Derived Short-Chain Fatty Acids
Short Talk: Control of Salmonella Virulence by Microbiota-Derived Short-Chain Fatty Acids
7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
8:00—11:15 AM
Dealing with Microbiome Complexity
Meeting has ended...abstracts no longer viewable online.
*
Joël Doré,
INRA / MetaGenoPolis, France
Ruth E. Ley,
Max Planck Institute for Developmental Biology, Germany
Sphingolipid Production by Gut Microbes Impacts Host Metabolism
Sphingolipid Production by Gut Microbes Impacts Host Metabolism
Natalia Shulzhenko,
Oregon State University, USA
Transkingdom Networks Uncovering Host-Microbiota Interactions
Transkingdom Networks Uncovering Host-Microbiota Interactions
Coffee Break
Peter J. Turnbaugh,
University of California, San Francisco, USA
Editing the Microbiome for Precision Medicine
Editing the Microbiome for Precision Medicine
Colin Hill,
University College Cork, Ireland
Phage - Drivers of Microbiome Structure
Phage - Drivers of Microbiome Structure
Abigail J. Johnson,
University of Minnesota, USA
Short Talk: Daily Microbiome-Diet Correspondence in Healthy Individuals
Short Talk: Daily Microbiome-Diet Correspondence in Healthy Individuals
Penny Oh,
Nanyang Technlogical University, Singapore
Short Talk: Friends with Benefits: Gram-Positive Bacteria Keeping Hepatic Clock in Sync
Short Talk: Friends with Benefits: Gram-Positive Bacteria Keeping Hepatic Clock in Sync
8:00—11:15 AM
Cancer, Metabolism and the Microbiome
Meeting has ended...abstracts no longer viewable online.
Laure Bindels,
Université Catholique de Louvain, Belgium
The Gut Microbiota in Cancer Cachexia
The Gut Microbiota in Cancer Cachexia
*
Ravid Straussman,
Weizmann Institute of Science, Israel
The Tumor Microbiome and its Effect on Chemoresistance
The Tumor Microbiome and its Effect on Chemoresistance
Coffee Break
Dimitra Lamprinaki,
Quadram Institute Bioscience, UK
Short Talk: Fusobacterium Nucleatum Is Involved in Tumor Progression through Interaction with Lectins Expressed by Myeloid Cells
Short Talk: Fusobacterium Nucleatum Is Involved in Tumor Progression through Interaction with Lectins Expressed by Myeloid Cells
Clarissa Campbell,
Memorial Sloan Ketttering Cancer Center, USA
Short Talk: Extrathymically-Generated Regulatory T Cells Shape the Metabolic Function of the Intestinal Microbiota
Short Talk: Extrathymically-Generated Regulatory T Cells Shape the Metabolic Function of the Intestinal Microbiota
Marc A. Sze,
University of Michigan, USA
Short Talk: The Relationship between the Microbiota and Short-Chain Fatty Acid Levels in Individuals with and without Colorectal Lesion
Short Talk: The Relationship between the Microbiota and Short-Chain Fatty Acid Levels in Individuals with and without Colorectal Lesion
Andriy Morgun,
Oregon State University, USA
Short Talk: Transkingdom Network Reveals Bacterial Players Associated with Cervical Cancer Gene Expression Program
Short Talk: Transkingdom Network Reveals Bacterial Players Associated with Cervical Cancer Gene Expression Program
Stephanie A. Cevallos,
University of California, Davis, USA
Short Talk: Investigating a Mechanistic Link Between ER Stress and Colorectal Cancer
Short Talk: Investigating a Mechanistic Link Between ER Stress and Colorectal Cancer
Yan Yan,
Harvard University, USA
Short Talk: Metagenomics of the Mucosal and Stool Microbiome in Lynch Syndrome
Short Talk: Metagenomics of the Mucosal and Stool Microbiome in Lynch Syndrome
5:00—6:45 PM
Panel: Faculty and Industry Working Together for Innovation
*
Nathalie Delzenne,
Université Catholique de Louvain, Belgium
Matthew Henn,
Seres Therapeutics, USA
Bugs as Drugs
Bugs as Drugs
Henry J. Haiser,
Novartis Institutes for BioMedical Research, USA
Microbiome Research at NIBR—Microbial Metabolites that Modulate Host Functions
Microbiome Research at NIBR—Microbial Metabolites that Modulate Host Functions
Joël Doré,
INRA / MetaGenoPolis, France
Preserving and Restoring Man-Microbes Symbiosis
Preserving and Restoring Man-Microbes Symbiosis
5:00—6:45 PM
The Microbiota in Cancer Treatment Toxicities and Immune Response
Meeting has ended...abstracts no longer viewable online.
*
Matthew R. Redinbo,
University of North Carolina at Chapel Hill, USA
Targeted Inhibitors for the Gut Microbiome
Targeted Inhibitors for the Gut Microbiome
Kristen M. Larsen,
University of South Carolina, USA
Short Talk: The Role of the Microbiome in Colorectal Cancer Development and Response to 5-Fluoruracil (5-FU) in ApcMin/+ Mice
Short Talk: The Role of the Microbiome in Colorectal Cancer Development and Response to 5-Fluoruracil (5-FU) in ApcMin/+ Mice
Thomas Gajewski,
University of Chicago, USA
Anti-Tumor Immune Responses and the Commensal Microbiota
Anti-Tumor Immune Responses and the Commensal Microbiota
Patricia Diaz,
University of Connecticut Health Center, USA
Short Talk: Disruption of Oral Homeostasis by Chemotherapeutic Cancer Treatment
Short Talk: Disruption of Oral Homeostasis by Chemotherapeutic Cancer Treatment
6:45—7:00 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Meeting has ended...abstracts no longer viewable online.
6:45—7:00 PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Meeting has ended...abstracts no longer viewable online.
7:00—8:00 PM
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
8:00—11:00 PM
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.
*Session Chair †Invited, not yet responded.
We gratefully acknowledge support for this conference from:
Keystone Symposia thanks our Sponsors for generously supporting this meeting:
|
|
We gratefully acknowledge additional support from these exhibitors at this conference:
|
|
Please stop by to meet these exhibitors during the conference.
We gratefully acknowledge the generous grant for this conference provided by:
We gratefully acknowledge additional support for this conference from:
|
|
|
|
|
|
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Development, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org, Phone:+1 970-262-2676 |
